Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Li‐Ping Ge
Observed names:
L. P. Ge,
L.- P. Ge,
L.-P. Ge,
Li-Ping Ge,
Liping Ge,
Li‐Ping GE
show all 6
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Shanghai Stomatological Hospital,
Fudan University Shanghai Cancer Center,
Shanghai Cancer Institute,
Affiliated Hospital of Jiangsu University,
Zhongshan Hospital
show all 7
ORCID:
0000-0002-3578-0073
Observed ORCID:
0000-0002-3578-0073
OpenAlex ID:
A5102857640
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
2022
·
Yi Xiao
, Ding Ma
, et al.
·
Cell Research
·
368
PDF
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer
2020
·
Xi Jin
, Li-Ping Ge
, et al.
·
Molecular Cancer
·
101
PDF
Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer
2014
·
He-Guo Jiang
, Jian Li
, et al.
·
Medical Oncology
·
63
SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
2020
·
Xi-Yu Liu
, Wang Jiang
, et al.
·
Theranostics
·
60
ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer
2024
·
Li-Ping Ge
, Xi Jin
, et al.
·
Cell Research
·
56
PDF
DNAzyme-based faithful probing and pulldown to identify candidate biomarkers of low abundance
2023
·
Qinqin Hu
, Zongxuan Tong
, et al.
·
Nature Chemistry
·
50
Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study
2018
·
Li-Ping Ge
, Xi-Yu Liu
, et al.
·
Cancer Management and Research
·
44
PDF
Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy
2014
·
L.-P. Ge
, J. Li
, et al.
·
Clinical & Translational Oncology
·
41
Survivin and Smac Gene Expressions but not Livin Are Predictors of Prognosis in Non-small Cell Lung Cancer Patients Treated with Adjuvant Chemotherapy Following Surgery
2010
·
C. H. Dai
, J. Li
, et al.
·
Japanese Journal of Clinical Oncology
·
39
Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor
2021
·
Li-Ping Ge
, Xi Jin
, et al.
·
Oncogene
·
33
Prognostic value of survivin, X‐linked inhibitor of apoptosis protein and second mitochondria‐derived activator of caspases expression in advanced non‐small‐cell lung cancer patients
2010
·
Ping CHEN
, Jian LI
, et al.
·
Respirology
·
31
LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer
2013
·
Jian Li
, Shun-Bing Shi
, et al.
·
Translational research
·
24
Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer
2012
·
Jian Li
, Ping Chen
, et al.
·
International Journal of Cancer
·
24
Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis
2013
·
J. Li
, Z.-N. Li
, et al.
·
Clinical & Translational Oncology
·
13
Establishment and validation of individualized clinical prognostic markers for LUAD patients based on autophagy-related genes
2022
·
Yuchang Fei
, Junyi Xu
, et al.
·
Aging
·
12
PDF
Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion
2012
·
Jian Li
, Zhen-Nan Li
, et al.
·
Tumor Biology
·
12
Targeting transposable elements in cancer: developments and opportunities
2024
·
Zi-Yu Wang
, Li-Ping Ge
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
11
Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion
2014
·
W. Sun
, J. Li
, et al.
·
QJM
·
11
Survivin mRNA expression in blood as a predictor of the response to EGFR-tyrosine kinase inhibitors and prognosis in patients with non-small cell lung cancer
2014
·
Wei-Lin Shi
, Jian Li
, et al.
·
Medical Oncology
·
10
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
2025
·
Lei Fan
, Wen-Juan Zhang
, et al.
·
Cancer Cell
·
9
Psychological Stress and Its Correlations to Patients with Acute Lymphedema After Breast Cancer Surgery
2024
·
Li-Ping Ge
, Lichen Tang
, et al.
·
Breast Cancer Targets and Therapy
·
6
PDF
CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer
2024
·
Xiaolin Lu
, Li-Ping Ge
, et al.
·
Frontiers in Oncology
·
6
PDF
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations
2020
·
Yi-Zhou Jiang
, Li-Ping Ge
, et al.
·
Breast Cancer Research and Treatment
·
6
Combination of autophagy inhibitors with high-dose CDK4/6 inhibitors offers new hope for advanced HR+/HER2− breast cancer
2025
·
Li-Ping Ge
, Yi-Zhou Jiang
·
Med
·
4
Current and future therapies for triple-negative breast cancer
2026
·
Zi-Xun Wang
, Xi-Yu Liu
, et al.
·
Journal of Hematology & Oncology
·
3
PDF
Show more works
View as search
Works count:
32
Citation count:
1,038
H-index:
13
I10-index:
19
Year
Topic
Type